CBD risks and the chance to rein in supplements
With medical and recreational marijuana being legalized in states across the country, cannabis and related products are hitting an eager market, but often without scientific studies to back up product claims. That puts consumers at a disadvantage, but the situation may have a silver lining. Harvard Medical School Associate Professor Pieter Cohen and Joshua Sharfstein… Read More »